The Recall Desk
ModerateFDA (Drugs)·D-0585-2026·Announced 2026-06-17

Primidone tablets recalled over potential acemetacin cross-contamination at API manufacturer

Primidone Tablets, USP, 50 mg, from Amneal are being recalled over the potential for cross-contamination with acemetacin API due to an issue at the API manufacturer. 27,936 bottles affected.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA graded this Class III, which the rubric places in the 1-2 band, and the source describes a potential cross-contamination rather than a confirmed one.

Plain-English summary

Primidone Tablets, USP, 50 mg, 100 tablets per bottle, prescription only, manufactured by Amneal Pharmaceuticals Pvt. Ltd. of Ahmedabad, India and distributed by Amneal Pharmaceuticals LLC of Bridgewater, New Jersey, are being recalled. The action covers 27,936 bottles of 100 tablets.

The stated reason is cross-contamination with other products, due to a potential for cross-contamination with acemetacin API arising from an issue at the API manufacturer. The FDA classified the action as Class III, its least serious classification, which is applied where use of the product is not likely to cause adverse health consequences.

The affected lot is AM251676. Distribution was nationwide within the USA.

Patients should not stop taking a prescribed medicine without advice. Anyone holding the affected lot should speak to their pharmacist or prescriber and follow the instructions issued by the firm.

The recalled product

Product
PRIMIDONE (PRIMIDONE)
Brand
PRIMIDONE

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot AM251676
  • EXP 11/31/2028

Distribution

Distributed nationwide across the United States.